NO159595C - Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte 6-fenyl-3(2h)-pyridazinonderivater. - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte 6-fenyl-3(2h)-pyridazinonderivater.Info
- Publication number
- NO159595C NO159595C NO82823128A NO823128A NO159595C NO 159595 C NO159595 C NO 159595C NO 82823128 A NO82823128 A NO 82823128A NO 823128 A NO823128 A NO 823128A NO 159595 C NO159595 C NO 159595C
- Authority
- NO
- Norway
- Prior art keywords
- substituted
- phenyl
- compounds
- pyridazinones
- dihydro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D521/00—Heterocyclic compounds containing unspecified hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/302,181 US4353905A (en) | 1981-09-17 | 1981-09-17 | Substituted 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones and 6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones |
| US40248882A | 1982-07-27 | 1982-07-27 | |
| US40797382A | 1982-08-13 | 1982-08-13 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO823128L NO823128L (no) | 1983-03-18 |
| NO159595B NO159595B (no) | 1988-10-10 |
| NO159595C true NO159595C (no) | 1989-01-18 |
Family
ID=27404868
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO82823128A NO159595C (no) | 1981-09-17 | 1982-09-15 | Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte 6-fenyl-3(2h)-pyridazinonderivater. |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0075436B1 (no) |
| KR (1) | KR880001623B1 (no) |
| AT (1) | ATE18909T1 (no) |
| AU (1) | AU563448B2 (no) |
| CA (1) | CA1190548A (no) |
| DD (1) | DD208615A5 (no) |
| DE (1) | DE3270274D1 (no) |
| DK (1) | DK414482A (no) |
| ES (1) | ES515743A0 (no) |
| FI (1) | FI76084C (no) |
| GR (1) | GR76999B (no) |
| HU (1) | HU190412B (no) |
| IE (1) | IE54101B1 (no) |
| IL (1) | IL66815A (no) |
| NO (1) | NO159595C (no) |
| NZ (1) | NZ201929A (no) |
| PH (1) | PH19332A (no) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3212304A1 (de) * | 1982-04-02 | 1983-10-06 | Nattermann A & Cie | Imidazolylphenyl-tetrahydropyridazine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate |
| DE3241102A1 (de) * | 1982-11-06 | 1984-05-10 | A. Nattermann & Cie GmbH, 5000 Köln | Imidazolylalkylthienyl-tetrahydropyridazine und verfahren zu ihrer herstellung |
| GB8310435D0 (en) * | 1983-04-18 | 1983-05-25 | Fujisawa Pharmaceutical Co | Triazine derivatives |
| DE3321012A1 (de) * | 1983-06-10 | 1984-12-13 | A. Nattermann & Cie GmbH, 5000 Köln | Substituierte 4,5-dihydro-6-(thien-2-yl)-3(2h)-pyridazinone und 6-(thien-2-yl)-3(2h)-pyridazinone sowie verfahren zu ihrer herstellung |
| US4599332A (en) * | 1983-12-07 | 1986-07-08 | Warner-Lambert Company | 4,5-dihydro-6-[2-[4-(1H-imidazol-1-yl)phenyl]-ethenyl]-3(2H)-pyridazinones and related compounds |
| DE3401911A1 (de) * | 1984-01-20 | 1985-08-01 | A. Nattermann & Cie GmbH, 5000 Köln | Substituierte 4,5-dihydro-6-vinyl-3(2h)-pyridazinone und 6-vinyl-3(2h)-pyridazinone sowie verfahren zu ihrer herstellung |
| DE3407509A1 (de) * | 1984-03-01 | 1985-09-05 | A. Nattermann & Cie GmbH, 5000 Köln | Neue arzneimittelkombination zur behandlung von bluthochdruck und thromboembolischen erkrankungen |
| US4584299A (en) * | 1984-05-21 | 1986-04-22 | Warner-Lambert Company | Method of treating heart failure and medicaments therefor |
| DE3425632A1 (de) * | 1984-07-12 | 1986-01-16 | Basf Ag, 6700 Ludwigshafen | (pyrrol-1-yl)-phenyl-dihydropyridazinone, ihre herstellung und verwendung |
| JPS61158969A (ja) * | 1984-12-24 | 1986-07-18 | ワーナー‐ランバート・コンパニー | ４，５‐ジヒドロ‐４，４‐ジアルキル‐６‐（置換）フエニル‐３（２ｈ）‐ピリダジノン類 |
| GB8502267D0 (en) * | 1985-01-30 | 1985-02-27 | Pfizer Ltd | Quinolone inotropic agents |
| IL79280A (en) * | 1985-07-05 | 1990-07-12 | Smith Kline French Lab | 4-(6-oxo-dihydro or tetrahydropyridazin-3-yl)benzene derivatives,their preparation and pharmaceutical compositions containing them |
| US4783463A (en) * | 1985-10-23 | 1988-11-08 | Rorer Pharmaceutical Corporation | Pyridyl-pyridazinone and pyridyl-pyrazolinone compounds and their use in the treatment of congestive heart failure |
| US4826835A (en) * | 1985-10-23 | 1989-05-02 | Rorer Pharmaceutical Corporation | Pyridyl-pyridazinone and pyridyl-pyrazolinone compounds and their use in the treatment of congestive heart failure |
| DE3600275A1 (de) * | 1986-01-08 | 1987-07-09 | Basf Ag | Substituierte pyrrol-1-ylphenyldihydropyridazinone, ihre herstellung und verwendung |
| DE3626865A1 (de) * | 1986-08-08 | 1988-02-11 | Boehringer Mannheim Gmbh | Neue pyridazinon-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| US4888169A (en) * | 1986-10-14 | 1989-12-19 | Norden Laboratories, Inc. | Bordetella Bronchiseptica vaccine |
| US4970210A (en) * | 1987-07-17 | 1990-11-13 | Abbott Laboratories | Triazinone lipoxygenase compounds |
| DE68917485T2 (de) * | 1988-01-23 | 1995-02-09 | Kyowa Hakko Kogyo Kk | Pyridazinon-Derivate und diese enthaltende pharmazeutische Zubereitungen. |
| DE3804490A1 (de) * | 1988-02-12 | 1989-08-24 | Heumann Pharma Gmbh & Co | Substituierte 6-phenyldihydro-3(2h)-pyridazinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| DE3814057A1 (de) * | 1988-04-26 | 1989-11-09 | Heumann Pharma Gmbh & Co | 6-oxo-pyridazinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| DE3826855A1 (de) * | 1988-08-06 | 1990-02-15 | Cassella Ag | 4,5-dihydro-3(2h)-pyridazinone, verfahren zu ihrer herstellung und ihre verwendung |
| DE3913597A1 (de) * | 1989-04-25 | 1990-11-08 | Heumann Pharma Gmbh & Co | Diazinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| DK40192D0 (da) * | 1992-03-26 | 1992-03-26 | Neurosearch As | Imidazolforbindelser, deres fremstilling og anvendelse |
| US7462613B2 (en) | 2002-11-19 | 2008-12-09 | Sanofi-Aventis Deutschland Gmbh | Pyridazinone derivatives as pharmaceuticals and pharmaceutical compositions containing them |
| US7309701B2 (en) | 2002-11-19 | 2007-12-18 | Sanofi-Aventis Deutschland Gmbh | Pyridazinone derivatives as pharmaceuticals and pharmaceutical compositions containing them |
| US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| EP1604988A1 (en) | 2004-05-18 | 2005-12-14 | Sanofi-Aventis Deutschland GmbH | Pyridazinone derivatives, methods for producing them and their use as pharmaceuticals |
| EP1598348A1 (en) | 2004-05-18 | 2005-11-23 | Aventis Pharma Deutschland GmbH | Novel pyridazinone derivatives as inhibitors of CDK2 |
| TWI375669B (en) | 2006-03-17 | 2012-11-01 | Sumitomo Chemical Co | Pyridazinone compound and use thereof |
| MY148634A (en) | 2006-07-25 | 2013-05-15 | Cephalon Inc | Pyridazinone derivatives |
| US7879802B2 (en) | 2007-06-04 | 2011-02-01 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| AU2009256157B2 (en) | 2008-06-04 | 2014-12-18 | Bausch Health Ireland Limited | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| JP2011528375A (ja) | 2008-07-16 | 2011-11-17 | シナジー ファーマシューティカルズ インコーポレイテッド | 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| CA3100941C (en) | 2011-03-01 | 2024-03-05 | Synergy Pharmaceuticals Inc. | Process of preparing guanylate cyclase c agonists |
| JP6499591B2 (ja) | 2013-02-25 | 2019-04-10 | シナジー ファーマシューティカルズ インコーポレイテッド | 結腸洗浄において用いるためのグアニル酸シクラーゼ受容体アゴニスト |
| JP2016514671A (ja) | 2013-03-15 | 2016-05-23 | シナジー ファーマシューティカルズ インコーポレイテッド | グアニル酸シクラーゼのアゴニストおよびその使用 |
| AU2014235209B2 (en) | 2013-03-15 | 2018-06-14 | Bausch Health Ireland Limited | Guanylate cyclase receptor agonists combined with other drugs |
| AU2014274812B2 (en) | 2013-06-05 | 2018-09-27 | Bausch Health Ireland Limited | Ultra-pure agonists of guanylate cyclase C, method of making and using same |
| AU2014305843B2 (en) | 2013-08-09 | 2019-08-29 | Ardelyx, Inc. | Compounds and methods for inhibiting phosphate transport |
| CN114340631A (zh) | 2019-05-21 | 2022-04-12 | 阿德利克斯股份有限公司 | 用于降低患者的血清磷酸盐的组合 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1383906A (en) * | 1971-02-22 | 1974-02-12 | Bdh Pharmaceuticals Ltd | Pyridazinones |
| BE790106A (fr) * | 1971-10-14 | 1973-04-13 | Basf Ag | Dihydropyridazones, leur preparation et leurs utilisations therapeutiques |
| DE3130251A1 (de) * | 1981-07-31 | 1983-02-17 | A. Nattermann & Cie GmbH, 5000 Köln | 6-(4-((omega)-(1-imidazolyl)-alkyl)-phenyl)-3-oxo -2,3,4,5-tetrahydro-pyridazine und deren saeureadditionssalze, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate |
-
1982
- 1982-09-14 HU HU822925A patent/HU190412B/hu not_active IP Right Cessation
- 1982-09-15 EP EP82304855A patent/EP0075436B1/en not_active Expired
- 1982-09-15 KR KR8204179A patent/KR880001623B1/ko not_active Expired
- 1982-09-15 CA CA000411513A patent/CA1190548A/en not_active Expired
- 1982-09-15 FI FI823184A patent/FI76084C/fi not_active IP Right Cessation
- 1982-09-15 AU AU88409/82A patent/AU563448B2/en not_active Ceased
- 1982-09-15 ES ES515743A patent/ES515743A0/es active Granted
- 1982-09-15 DE DE8282304855T patent/DE3270274D1/de not_active Expired
- 1982-09-15 GR GR69283A patent/GR76999B/el unknown
- 1982-09-15 DD DD82243270A patent/DD208615A5/de not_active IP Right Cessation
- 1982-09-15 IE IE2250/82A patent/IE54101B1/en unknown
- 1982-09-15 NO NO82823128A patent/NO159595C/no unknown
- 1982-09-15 AT AT82304855T patent/ATE18909T1/de not_active IP Right Cessation
- 1982-09-15 NZ NZ201929A patent/NZ201929A/en unknown
- 1982-09-15 PH PH27877A patent/PH19332A/en unknown
- 1982-09-16 IL IL66815A patent/IL66815A/xx unknown
- 1982-09-16 DK DK414482A patent/DK414482A/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| FI76084C (fi) | 1988-09-09 |
| AU563448B2 (en) | 1987-07-09 |
| ES8400414A1 (es) | 1983-10-16 |
| DK414482A (da) | 1983-03-18 |
| NO823128L (no) | 1983-03-18 |
| DE3270274D1 (en) | 1986-05-07 |
| ES515743A0 (es) | 1983-10-16 |
| IE822250L (en) | 1983-03-17 |
| DD208615A5 (de) | 1984-04-04 |
| AU8840982A (en) | 1983-03-24 |
| EP0075436A1 (en) | 1983-03-30 |
| NZ201929A (en) | 1985-11-08 |
| IL66815A0 (en) | 1982-12-31 |
| IE54101B1 (en) | 1989-06-21 |
| HU190412B (en) | 1986-09-29 |
| KR880001623B1 (ko) | 1988-09-02 |
| PH19332A (en) | 1986-03-20 |
| NO159595B (no) | 1988-10-10 |
| ATE18909T1 (de) | 1986-04-15 |
| FI823184A0 (fi) | 1982-09-15 |
| EP0075436B1 (en) | 1986-04-02 |
| FI823184L (fi) | 1983-03-18 |
| KR840001570A (ko) | 1984-05-07 |
| FI76084B (fi) | 1988-05-31 |
| CA1190548A (en) | 1985-07-16 |
| GR76999B (no) | 1984-09-04 |
| IL66815A (en) | 1986-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO159595C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte 6-fenyl-3(2h)-pyridazinonderivater. | |
| JP4594526B2 (ja) | 置換４−アミノ−２−アリールピリミジン、それらの製造、それらの使用およびそれらを含有する医薬製剤 | |
| WO1999010332A1 (en) | Prostaglandin endoperoxide h synthase biosynthesis inhibitors | |
| US5808065A (en) | Pyridazinone derivatives and processes for preparing the same | |
| US4474785A (en) | 2-Aryl-3,4-diazabicyclo[4.n.O]alk-2-en-5-ones, and compositions for treating thermo-embolic disorders | |
| US4521416A (en) | 4,5-Dihydro-6-[(substituted)-1H-imidazol-4-yl or 5-yl]-3(2H)-pyridazinones and 6-[(substituted)-1H-imidazol-4-yl or 5-yl]-3(2H)-pyridazinones | |
| KR880003920A (ko) | 피리다지논 유도체 | |
| Sircar et al. | Cardiotonic agents. 6. Synthesis and inotropic activity of 2, 4-dihydro-5-[4-(1H-imidazol-1-yl) phenyl]-3H-pyrazol-3-ones: ring-contracted analogs of imazodan (CI-914) | |
| CA1077937A (en) | Process for preparing new pyridazinylhydrazines | |
| ES8704479A1 (es) | Procedimiento para preparar piridazinonas alquil-sustituidas | |
| US6525053B1 (en) | Prostaglandin endoperoxide H synthase biosynthesis inhibitors | |
| US4971968A (en) | Pyridazinone derivatives and salts thereof | |
| US4772598A (en) | 2-aryl-3,4-diazabicyclo(4.n.O)alk-2-en-5-ones for the preparation of an agent for treating cardiac insufficiency | |
| SE8102660L (sv) | 6-(pyridinyl)-4-substituerade-3-(2h)-pyridazinoner, anvendbara som kardiotoniska medel, och framstellning derav | |
| MXPA99011772A (en) | Prostaglandin endoperoxide h synthase biosynthesis inhibitors |